Addus HomeCare (NASDAQ:ADUS – Free Report) had its target price reduced by Stephens from $110.00 to $105.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have an overweight rating on the stock. A number of other research analysts also recently issued reports on the company. Oppenheimer reissued an outperform rating […]